Meet our partners
BioCity specialises in the creation and development of life science businesses. It provides homes and access to high-end equipment, shared services, training, business support and access to investment for new and growing bioscience businesses. Nearly 200 companies are based in a BioCity business incubator, making the BioCity network one of the largest concentrations of life science businesses in the UK. The 91% survival rate of companies at BioCity in Nottingham tangibly demonstrates one of the benefits to a company of being located within the BioCity network. In 2012, BioCity established BioCity Scotland, near Glasgow and in 2013 BioHub at Alderley Park and later MediCity on the Boots campus in Nottingham. Read more at

Feb 2016 BioCity and Waters celebrate new Open Access Analytical Lab

Jan 2016 First Tenants Move In at MediCity Scotland

Nov 2015 Alfacyte Ltd moves to BioCity Scotland after securing £350k of investment in peanut allergy vaccine

OneStart Europe Vision Film 2016

  • Claire Brown, Investment Manager, Alderley Park Ventures / BioCity 
  • Dan Perez, CEO & Founder, Oxbridge Biotech Roundtable 
  • Nooman Haque, Director of Life Sciences, Silicon Valley Bank
  • Richard Mason, Head of Johnson & Johnson Innovation London, Johnson & Johnson 
  • Jeanne Bolger, VP Venture Investing, Johnson & Johnson Innovation - JJDC
  • Matthew Foy, Partner, SR One
  • Sarah Haywood, CEO, MedCity 
  • Matthias Essenpreis, CTO (Diagnostics), F-Hoffman-La Roche Ltd. 
  • Rachel Moss, Associate Principal, McKinsey and Company 
  • Lynne Murray, Partnering and Strategy, MedImmune
  • Aric Orbach, Head of Pharmacology, Teva Pharmaceutical Industries 
  • Stephen Reese, Partner, Olswang LLP 
  • Ilan Zipkin, Investment Director, Takeda Ventures Inc. 

From the OneStart London Bootcamp 2016 

Panel Discussion

Panel Discussion: Accessing and Interacting with Industry

  • Rachel Moss, PhD, Associate Prinicipal, McKinsey and Company (Chair) 
  • Claire Brown, PhD, Investment Manager, Alderley Park Ventures / BioCity 
  • Georg Buchner, PhD MBA, Licensing Director, Amgen 
  • Elena Fernandez-Kleinlein, Senior Director, Consumer Scientific Innovation, Johnson & Johnson Innovation London 
  • Will West, PhD, President & CEO, Cancer Targeting Systems Inc. 
  • Aric Orbach, DVM, Head of Pharmacology, Teva Pharmaceutical Industries 
Claire Brown
Investment Manager, Alderley Park Ventures + more
I manage a life science focused seed fund leading the identification, evaluation & diligence on opportunities for investment (devices, products and platform technologies) having previously, at AstraZeneca, led all aspects of in-licensing business development activities from ‘search and evaluate’ to delivery of business case proposals.
Teams Mentored